These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14207669)

  • 1. TREATMENT OF PARKINSONISM IN ELDERLY PATIENTS WITH COSALDON.
    MUSTARD DM
    Br J Clin Pract; 1964 Sep; 18():537-8. PubMed ID: 14207669
    [No Abstract]   [Full Text] [Related]  

  • 2. [REPORT ON THE SUBJECT OF RESULTS OBTAINED WITH COSALDON TREATMENT IN 35 PATIENTS OF THE INSTITUT NOTRE-DAME AT BRUGES-ST. MICHEL DURING THE PERIOD FROM JUNE TO DECEMBER, 1963].
    DUCHENE W
    Scalpel (Brux); 1964 Oct; 117():882-5. PubMed ID: 14230448
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the applicability of cosaldon in the treatment of cerebral sclerotic parkinsonism].
    EHLERS G
    Munch Med Wochenschr; 1959 Aug; 101():1355-7. PubMed ID: 13819571
    [No Abstract]   [Full Text] [Related]  

  • 4. A REPORT ON THE USE OF COSALDON IN GENERAL PRACTICE.
    WALDRON DH
    Br J Clin Pract; 1963 Dec; 17():733-4. PubMed ID: 14084642
    [No Abstract]   [Full Text] [Related]  

  • 5. A CONTROLLED TRIAL OF COSALDON IN ARTERIOSCLEROTIC DEMENTIA.
    COOPER AJ
    Br J Psychiatry; 1964 May; 110():415-8. PubMed ID: 14142534
    [No Abstract]   [Full Text] [Related]  

  • 6. [On Cosaldin and psychic functions in the elderly. Criticism of the method used in a psychopharmacological study].
    GRUVSTAD M
    Sven Lakartidn; 1963 Apr; 60():1100-5. PubMed ID: 13950970
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of cerebral arteriosclerosis with cosaldon].
    SPERLING R
    Med Klin; 1960 May; 55():845-7. PubMed ID: 13833290
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of cosaldon in cerebral arteriosclerosis.
    FELSTEIN IL
    Br J Clin Pract; 1963 Aug; 17():448-9. PubMed ID: 13962885
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON ELECTRORHEOGRAPHIC OBJECTIVE EVALUATION OF SUBSTANCES WITH CENTRAL NERVOUS SYSTEM ACTION. SODIUM NICOTINATE AND SODIUM BETA,BETA-PENTAMETHYLENE-GAMMA-HYDROXYBUTYRATE MONOHYDRATE].
    KUNERT W; DUNKER R
    Arzneimittelforschung; 1963 Nov; 13():986-8. PubMed ID: 14210439
    [No Abstract]   [Full Text] [Related]  

  • 10. PREVENTION OF CORONARY THROMBOSIS: CLINICAL OBSERVATIONS FOR 1 TO 10 YEARS.
    STERN ML
    Curr Ther Res Clin Exp; 1965 Mar; 7():195-203. PubMed ID: 14265008
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cosaldon in the treatment of cerebral arteriosclerosis].
    Dzialek E; Orzechowska-Wolczyk M; Zawadzki Z
    Wiad Lek; 1975 Sep; 28(18):1547-9. PubMed ID: 1163042
    [No Abstract]   [Full Text] [Related]  

  • 12. [LONG-TERM THERAPY WITH COSALDON IN BLOOD CIRCULATION DISORDERS OF THE RETINA AND CHOROID].
    NEUBAUER H
    Klin Monbl Augenheilkd; 1965 Jun; 146():646-65. PubMed ID: 14315871
    [No Abstract]   [Full Text] [Related]  

  • 13. [Improvement of brain circulation with cosaldon as a therapeutic measure in pediatrics].
    HERBST R
    Munch Med Wochenschr; 1962 Jun; 104():1184-6. PubMed ID: 13906651
    [No Abstract]   [Full Text] [Related]  

  • 14. [BETAIN NICOTINATE IN PROLONGED ORAL FIBRINOLYTIC THERAPY].
    FRANDOLI G; GIBELLI A; TURAZZA G
    Gazz Int Med Chir; 1964 Nov; 68():2065-83. PubMed ID: 14242275
    [No Abstract]   [Full Text] [Related]  

  • 15. [7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1, 3-DIMETHYL-XANTHINE NICOTINATE IN CHRONIC OBLITERATING ANGIOPATHIES].
    FERNANDEZBLANCO E; DEFERNANDEZBLANCO JF; AGUSTINARZENO J
    Sem Med; 1963 Nov; 123():1733-40. PubMed ID: 14110181
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of Cosaldin the capacity for orientation, memory and thinking in elderly patients with cerebral arteriosclerosis].
    BJURWILL B
    Sven Lakartidn; 1963 Jan; 60():192-9. PubMed ID: 13971348
    [No Abstract]   [Full Text] [Related]  

  • 17. COMPARISON OF THE EFFECTS OF HEPARIN SODIUM, XANTHINOL NIACINATE (COMPLAMIN) AND 2-DIMETHYL-AMINOETHANOL (DEANER) IN INSTITUTIONALIZED GERIATRIC GROUPS.
    LAWRENCE RM; LEICHMAN NS
    J Am Geriatr Soc; 1965 Apr; 13():325-42. PubMed ID: 14280420
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON THE POSSIBILITIES OF DEXTRAN THERAPY OF SENILE ATHEROSCLEROSIS].
    PATAKY J; D ENES L; JUHASZ G; LUSZTIG G
    Magy Belorv Arch (1955); 1963 May; 16():85-9. PubMed ID: 14062075
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with new Cosaldon forms].
    Dammann C
    Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cerebral sclerosis and its treatment with cosaldon].
    MEYER J
    Med Klin; 1957 Jun; 52(24):1073-4. PubMed ID: 13451071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.